JP2022515721A5 - - Google Patents

Info

Publication number
JP2022515721A5
JP2022515721A5 JP2021534207A JP2021534207A JP2022515721A5 JP 2022515721 A5 JP2022515721 A5 JP 2022515721A5 JP 2021534207 A JP2021534207 A JP 2021534207A JP 2021534207 A JP2021534207 A JP 2021534207A JP 2022515721 A5 JP2022515721 A5 JP 2022515721A5
Authority
JP
Japan
Application number
JP2021534207A
Other languages
Japanese (ja)
Other versions
JPWO2020120979A5 (https=
JP2022515721A (ja
Filing date
Publication date
Priority claimed from GBGB1820320.8A external-priority patent/GB201820320D0/en
Application filed filed Critical
Publication of JP2022515721A publication Critical patent/JP2022515721A/ja
Publication of JPWO2020120979A5 publication Critical patent/JPWO2020120979A5/ja
Publication of JP2022515721A5 publication Critical patent/JP2022515721A5/ja
Pending legal-status Critical Current

Links

JP2021534207A 2018-12-13 2019-12-13 FAPαに特異的な二環式ペプチドリガンド Pending JP2022515721A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1820320.8A GB201820320D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for FAPalpha
GB1820320.8 2018-12-13
PCT/GB2019/053535 WO2020120979A1 (en) 2018-12-13 2019-12-13 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPα

Publications (3)

Publication Number Publication Date
JP2022515721A JP2022515721A (ja) 2022-02-22
JPWO2020120979A5 JPWO2020120979A5 (https=) 2022-12-19
JP2022515721A5 true JP2022515721A5 (https=) 2022-12-19

Family

ID=65147028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021534207A Pending JP2022515721A (ja) 2018-12-13 2019-12-13 FAPαに特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220008545A1 (https=)
EP (1) EP3894005A1 (https=)
JP (1) JP2022515721A (https=)
CN (1) CN113507961A (https=)
GB (1) GB201820320D0 (https=)
WO (1) WO2020120979A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116474108A (zh) 2016-12-14 2023-07-25 普渡研究基金会 成纤维细胞活化蛋白(fap)-靶向成像和治疗
CN111118063B (zh) * 2019-12-05 2023-04-18 吉林大学 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031374A2 (en) * 2002-09-18 2004-04-15 Prosidion Ltd. Secondary binding site of dipeptidyl peptidase iv (dp iv)
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
US7374898B2 (en) * 2004-10-12 2008-05-20 The Research Foundation Of State University Of New York Peptide inhibitors against seprase
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
WO2007087131A2 (en) * 2006-01-05 2007-08-02 The Johns Hopkins University Peptide prodrugs
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
CN108383893A (zh) * 2011-08-30 2018-08-10 塔夫茨大学信托人 用于治疗实体瘤的fap-活化的蛋白酶体抑制剂
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
WO2018197893A1 (en) * 2017-04-27 2018-11-01 Bicycletx Limited Bicyclic peptide ligands and uses thereof

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)